People · Operator
Named in public records as an officer, director or promoter · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Omeros Corp | — | Biotechnology | Series B | $52.0M | $120.9M | — |
MARCIA S. KELBON at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MARCIA S. KELBON on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| DANIEL K. SPIEGELMAN | 1 | 4 |
| Ray S. Aspiri | 1 | 2 |
| LEROY E. HOOD | 1 | 1 |
| THOMAS J. CABLE | 1 | 1 |
| GREGORY A. DEMOPULOS | 1 | 1 |
| PETER A. DEMOPULOS | 1 | 1 |
| JEAN-PHILIPPE K. TRIPET | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.